|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.63 USD | +4.79% |
|
-0.83% | +23.74% |
| Dec. 11 | Stephens Initiates Oscar Health With Equalweight Rating, $17 Price Target | MT |
| Nov. 26 | Oscar Health Shares Rise After Piper Sandler Upgrade | MT |
| Capitalization | 4.4B 3.75B 3.5B 3.29B 6.06B 398B 6.62B 40.84B 15.84B 188B 16.5B 16.15B 685B | P/E ratio 2025 * |
-12.9x | P/E ratio 2026 * | -91.2x |
|---|---|---|---|---|---|
| Enterprise value | 2.06B 1.75B 1.64B 1.54B 2.84B 186B 3.1B 19.12B 7.42B 87.87B 7.72B 7.56B 321B | EV / Sales 2025 * |
0.17x | EV / Sales 2026 * | 0.17x |
| Free-Float |
78.1% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Oscar Health, Inc.
| 1 day | +4.79% | ||
| 1 week | -0.83% | ||
| Current month | -7.46% | ||
| 1 month | +10.13% | ||
| 3 months | -13.97% | ||
| 6 months | +15.97% | ||
| Current year | +23.74% |
| 1 week | 15.53 | 17.17 | |
| 1 month | 12.64 | 18.63 | |
| Current year | 11.2 | 23.8 | |
| 1 year | 11.2 | 23.8 | |
| 3 years | 2.05 | 23.8 | |
| 5 years | 2.05 | 37 | |
| 10 years | 2.05 | 37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mario Schlosser
CEO | Chief Executive Officer | 46 | 2012-11-30 |
Mark Bertolini
CEO | Chief Executive Officer | 68 | 2023-04-02 |
Richard Blackley
DFI | Director of Finance/CFO | 56 | 2023-08-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Schlosser
BRD | Director/Board Member | 46 | 2012-11-30 |
Joshua Kushner
CHM | Chairman | 39 | 2012-10-24 |
| Director/Board Member | 47 | 2021-01-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.79% | -0.83% | +21.92% | +518.22% | 4.4B | ||
| +0.43% | +4.22% | +25.40% | +58.45% | 8.58B | ||
| +0.52% | +7.01% | -26.06% | +15.07% | 6.12B | ||
| -0.81% | +3.10% | -14.58% | +98.92% | 4.91B | ||
| +1.17% | +2.68% | +23.66% | -3.77% | 2.23B | ||
| -0.41% | -1.57% | -31.94% | -32.52% | 1.57B | ||
| +0.07% | +2.59% | -11.58% | - | 1.54B | ||
| -3.83% | -9.83% | - | - | 913M | ||
| +1.47% | -0.76% | -23.59% | +33.44% | 853M | ||
| -1.06% | +0.54% | -41.53% | +59.54% | 481M | ||
| Average | +0.23% | +0.45% | -8.70% | +93.42% | 3.16B | |
| Weighted average by Cap. | +0.74% | +2.68% | +0.91% | +115.15% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 12.02B 10.24B 9.56B 9B 16.57B 1,089B 18.1B 112B 43.3B 513B 45.1B 44.15B 1,872B | 12.61B 10.74B 10.04B 9.44B 17.38B 1,142B 18.99B 117B 45.44B 538B 47.32B 46.32B 1,964B |
| Net income | -323M -275M -257M -242M -446M -29.29B -487M -3B -1.17B -13.81B -1.21B -1.19B -50.37B | 2.4M 2.05M 1.91M 1.8M 3.31M 218M 3.62M 22.34M 8.66M 103M 9.02M 8.83M 375M |
| Net Debt | -2.34B -1.99B -1.86B -1.75B -3.22B -212B -3.52B -21.72B -8.42B -99.83B -8.77B -8.59B -364B | -2.3B -1.96B -1.83B -1.72B -3.17B -208B -3.46B -21.33B -8.27B -98.05B -8.62B -8.44B -358B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 16.63 $ | +4.79% | 9,836,845 |
| 25-12-11 | 15.87 $ | +1.80% | 9,451,133 |
| 25-12-10 | 15.59 $ | -8.08% | 12,529,354 |
| 25-12-09 | 16.96 $ | +1.37% | 5,709,493 |
| 25-12-08 | 16.73 $ | -0.24% | 5,490,694 |
Delayed Quote Nyse, December 12, 2025 at 04:00 pm EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OSCR Stock
Select your edition
All financial news and data tailored to specific country editions
















